In conclusion, combination therapy is recommended for prediabetes management, as exercise improves insulin sensitivity and glucose homeostasis, while metformin, when administered under medical supervision, may additionally contribute to reductions in IMAT, particularly in individuals with high baseline levels and elevated metabolic risk. This evidence concerns the gene INS and prediabetes syndrome.